reportingrisk.com← the monitorSEC reporting failures, scored and checked against what happened next

Or browse all companies A–Z.

Cerenome, Inc.

CNSY · Nasdaq

No reporting failures in the last 12 months

It filed on time and stood behind its numbers. Of companies scoring zero, 4.0% were delisted, went bankrupt, restated or stopped filing within the following year.

—public float
2025-07-18most recent failure

Score over time

012202220232024202520262025-07-01 · score 12025-05-15 filed late (10-Q) · complex accounting2025-10-01 · score 22025-07-18 auditor change2025-05-15 filed late (10-Q) · complex accounting2026-01-01 · score 22025-07-18 auditor change2025-05-15 filed late (10-Q) · complex accounting2026-04-01 · score 22025-07-18 auditor change2025-05-15 filed late (10-Q) · complex accounting2026-07-01 · score 12025-07-18 auditor change

Hover or tap a dot to see the filings behind that score.

Why they said they were late

Plus Therapeutics, Inc. (the “Company”) is filing this Notification of Late Filing on Form 12b-25 with respect to its Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 (the “Quarterly Report”). The Company requires additional time to finalize the accounting treatment in respect of common stock purchase warrants issued pursuant to that certain securities purchase agreement, dated March 4, 2025, among the Company and the purchasers signatory thereto (the “March 2025 PIPE Transaction”). As a result of the foregoing, the Company is unable, without unreasonable effort or expense, to file its Quarterly Report by the prescribed due date of May 15, 2025. The Company is working diligently to complete the Form 10-Q as soon as possible. 2

NT 10-Q, filed 2025-05-15 · complex accounting

What it filed

2025-07-18auditor changed or resigned SEC →

2025-05-15filed late (10-Q)complex accounting SEC →

Plus Therapeutics, Inc. (the “Company”) is filing this Notification of Late Filing on Form 12b-25 with respect to its Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 (the “Quarterly Report”). The Company requires additional time to finalize the accounting treatment in respect of common stock purchase warrants issued pursuant to that certain securities purchase agreement, dated March 4, 2025, among the Company and the purchasers signatory thereto (the “March 2025 PIPE Transaction”). As a result of the foregoing, the Company is unable, without unreasonable effort or expense, to file its Quarterly Report by the prescribed due date of May 15, 2025. The Company is working diligently to complete the Form 10-Q as soon as possible. 2

About this score

reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.

Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.

See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.

Every item above is a filing this company made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not investment advice

reportingrisk.com← back to the monitorAll companies A-Z · RSS · found an error? hello@reportingrisk.com